Astrazeneca plc ADR (NASDAQ:AZN) has a beta value of 0.50 and has seen 5.52 million shares traded in the last trading session. The company, currently valued at $234.02B, closed the last trade at $75.48 per share which meant it gained $0.31 on the day or 0.41% during that session. The AZN stock price is -0.44% off its 52-week high price of $75.81 and 19.89% above the 52-week low of $60.47. The 3-month trading volume is 6.39 million shares.

Astrazeneca plc ADR (NASDAQ:AZN) trade information

Sporting 0.41% in the green in last session, the stock has traded in the green over the last five days, when the AZN stock price touched $75.48 or saw a rise of 1.44%. Year-to-date, Astrazeneca plc ADR shares have moved 12.07%, while the 5-day performance has seen it change 7.63%. Over the past 30 days, the shares of Astrazeneca plc ADR (NASDAQ:AZN) have changed 11.41%.

Astrazeneca plc ADR (AZN) estimates and forecasts

Figures show that Astrazeneca plc ADR shares have outperformed across the wider relevant industry. The company’s shares have gained 19.03% over the past 6 months, with this year growth rate of 10.47%, compared to 3.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 20.40% and 64.40% for the next quarter. Revenue growth from the last financial year stood is estimated to be 11.90%.

4 analysts offering their estimates for the company have set an average revenue estimate of $12.5 billion for the current quarter. 3 have an estimated revenue figure of $12.87 billion for the next quarter concluding in Sep 2024. Year-ago sales stood $10.96 billion and $11.55 billion respectively for this quarter and the next, and analysts expect sales will grow by 14.00% for the current quarter and 11.40% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.72% over the past 5 years. Earnings growth for 2024 is a modest 12.23% while over the next 5 years, the company’s earnings are expected to increase by 13.20%.

AZN Dividends

Astrazeneca plc ADR is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.45 at a share yield of 1.92%. The company’s dividend yield has gone up over the past 12 months.